Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | HRH1 | P35367 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL28230602 | 0.96 | CA2 (0.48) | CA2MAPK1ACE2CHRM1AKR1A1 | |
| SCHEMBL28089681 | 0.93 | ACE2 (0.62) | CA2MAPK1ACE2CHRM1AKR1A1 | |
| SCHEMBL27716926 | 0.92 | ACE2 (0.61) | CA2MAPK1ACE2CHRM1AKR1A1 | |
| SCHEMBL29124980 | 0.92 | ACE2 (0.61) | CA2MAPK1ACE2CHRM1AKR1A1 | |
| SCHEMBL16871793 | 0.92 | BLM (0.50) | CA2MAPK1ACE2CHRM1AKR1A1 | |
| SCHEMBL346871 | 0.92 | ACE2 (0.61) | CA2MAPK1ACE2CHRM1AKR1A1 | |
| SCHEMBL346624 | 0.92 | ACE2 (0.61) | CA2MAPK1ACE2CHRM1AKR1A1 | |
| SCHEMBL5878998 | 0.92 | CHRM1 (0.61) | CA2MAPK1ACE2CHRM1AKR1A1 | |
| SCHEMBL367223 | 0.92 | ACE2 (0.61) | CA2MAPK1ACE2CHRM1AKR1A1 | |
| SCHEMBL5878951 | 0.92 | CHRM1 (0.61) | CA2MAPK1ACE2CHRM1AKR1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108349919-B | Polyfunctional epoxy compound and curable composition containing the same | 日产化学工业株式会社 | 2022-06-03 | — | — | CN | disclosed |
| CN-108349919-A | Multi-functional epoxy compound and curable adhensive compositions containing it | 日产化学工业株式会社 | 2018-07-31 | — | — | CN | disclosed |
| CN-108350252-A | Epoxy reactive diluent and composition epoxy resin containing it | 日产化学工业株式会社 | 2018-07-31 | — | — | CN | disclosed |
| US-20170197902-A1 | METHOD FOR PRODUCING MULTIBRANCHED ALIPHATIC ESTER | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-07-13 | — | — | US | disclosed |
| US-20170197902-A1 | METHOD FOR PRODUCING MULTIBRANCHED ALIPHATIC ESTER | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-07-13 | — | — | US | disclosed |
| US-20150210660-A1 | ALICYCLIC EPOXY COMPOUND AND METHOD FOR PRODUCING SAME | DAICEL CORPORATION (JP) | 2015-07-30 | — | — | US | disclosed |
| CN-104583188-A | Alicyclic epoxy compound and method for producing same | DAICEL CORP | 2015-04-29 | — | — | CN | disclosed |
| US-7838584-B2 | Golf ball | BRIDGESTONE SPORTS CO., LTD. (JP) | 2010-11-23 | — | — | US | disclosed |
| US-7563179-B2 | Golf ball | BRIDGESTONE SPORTS CO., LTD. (JP) | 2009-07-21 | — | — | US | disclosed |
| US-20080076603-A1 | Golf ball | BRIDGESTONE SPORTS CO., LTD. (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20080039563-A1 | Golf ball | BRIDGESTONE SPORTS CO., LTD. | 2008-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150210660-A1 | ALICYCLIC EPOXY COMPOUND AND METHOD FOR PRODUCING SAME | OXER1, ALOX12, AKR1C1 | CA2 2654/4885MAPK1 1656/4885ACE2 1614/4885 |
| US-20170197902-A1 | METHOD FOR PRODUCING MULTIBRANCHED ALIPHATIC ESTER | ADH1A, ADH5, ADH1C | CA2 1232/4885MAPK1 3433/4885ACE2 3806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.